Cargando…
Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns – A systematic review
OBJECTIVE: Among the mechanisms proposed for the development of bronchopulmonary dysplasia is the increase in the pulmonary inflammatory process and oxidative stress. Thus, the control of this process may result in improvements in bronchopulmonary dysplasia-related outcomes. This study aims to analy...
Autores principales: | Moraes, Lucas Hirano Arruda, Coelho, Rachel Mocelin Dias, Neves dos Santos Beozzo, Glenda Priscila, Yoshida, Renata de Araújo Monteiro, de Albuquerque Diniz, Edna Maria, de Carvalho, Werther Brunow |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031365/ https://www.ncbi.nlm.nih.gov/pubmed/36436670 http://dx.doi.org/10.1016/j.jped.2022.10.007 |
Ejemplares similares
-
The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia
por: Gharehbaghi, Manizheh Mostafa, et al.
Publicado: (2021) -
A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia
por: Gharehbaghi, Manizheh M., et al.
Publicado: (2021) -
Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
por: McEvoy, Cindy T., et al.
Publicado: (2020) -
Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018) -
An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020)